Stimulant Effects in Attention Deficit Hyperactivity Disorder: Theoretical and Empirical Issues

Journal of Clinical Child and Adolescent Psychology

Volumn 30, Issue 1, 2001, Pages 98-109

  Denney, Colin B ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT; DOPAMINE; METHYLPHENIDATE;

ADOLESCENT; ANIMAL; ATTENTION DEFICIT DISORDER; CHILD; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; HUMAN; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL MODEL; RAT; REVIEW; TREATMENT OUTCOME;

ADOLESCENT; ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DISEASE MODELS, ANIMAL; DOPAMINE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; METHYLPHENIDATE; MICE; MODELS, PSYCHOLOGICAL; RATS; TREATMENT OUTCOME;

EID: 0035294051     PISSN: 15374416     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15374424JCCP3001_11     Document Type: Article

References (36)

1. American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders (3rd ed.). Washington, DC: Author.
2. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
3. Barkley, R. A. (1997). Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychological Bulletin, 12, 65-94.
4. Barkley, R. A. (1998). Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment (pp. 73-78). New York, New York: Guilford.
5. Biederman, J., Faraone, S. V., Keenan, K., & Tsuang, M. T. (1991). Evidence of familial American Psychiatric Association between attention deficit disorder and major affective disorders. Archives of General Psychiatry, 48, 633-642.
6. Biederman, J., Faraone, S. V., Keenan, K., Knee, D., Tsuang, M. T. (1990). Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 29, 526-533.
7. Biederman, J., Faraone, S. V., Keenan, K., Steingard, R., & Tsuang, M. T. (1991). Familial American Psychiatric Association between attention deficit disorder and anxiety disorders. American Journal of Psychiatry, 148, 251-256.
8. Cook, E. H., Stein, M. A., Krasowski, M. D., Cox, N. J., Olkon, D. M., Kieffer, J. E., & Leventhal, B. L. (1995). American Psychiatric Association of attention-deficit hyperactivity disorder and the dopamine transporter gene. American Journal of Human Genetics, 56, 993-998.
9. Denney, C. B., & Rapport, M. D. (1999). Predicting methylphenidate response in children with ADHD: Theoretical, conceptual, and empirical models. Journal of the American Academy of Child and Adolescent Psychiatry, 38(4), 393-401.
10. Douglas, V. I., Barr, R. G., Amin, K., O'Neill, M. E., & Britton, B. G. (1988). Dosage effects and individual responsivity to methylphenidate in attention deficit disorder. Journal of Child Psychology and Psychiatry, 29, 453-475.
11. Douglas, V. I., Barr, R. G., O'Neill, M. E., & Britton, B. G. (1986). Short term effects of methylphenidate on the cognitive, learning, and academic performance of children with attention deficit disorder in the laboratory and the classroom. Journal of Child Psychology and Psychiatry, 27, 191-211.
12. Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Levin, E. D., Jaber, M., & Caron, M. G. (1999). Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science, 283, 397-401.
13. Gill, M., Heron, S., Hawi, Z., & Fitzgerald, M. (1997). Confirmation of American Psychiatric Association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Molecular Psychiatry, 2, 311-313.
14. Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996). Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature, 379, 606-612.
15. Gjone, H., Stevenson, J., & Sundet, J. M. (1996). Genetic influence on parent-reported attention-related problems in a Norwegian general population twin sample. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 588-596.
16. Jacobson, N. S., & Truax, P. (1991). Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology, 59, 12-19.
17. Jacobvitz, D., Sroufe, L. A., Steward, M., & Leffert, N. (1990). Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs: A comprehensive review. Journal of the American Academy of Child and Adolescent Psychiatry, 29, 677-688.
18. Kagan, J. (1966). Reflection-impulsivity: The generality and dynamics of conceptual tempo. Journal of Abnormal Child Psychology, 71, 17-24.
19. La Hoste, G. J., Swanson, J. M., Wigal, S. B., Glabe, C., Wigal, T., King, N., & Kennedy, J. L. (1996). Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Molecular Psychiatry, 1, 121-124.
20. Levy, F., Hay, D. A., McStephen, M., Wood, C., & Waldman, I. (1997). Attention-deficit hyperactivity disorder: A category or a continuum? Genetic analysis of a large-scale twin study. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 737-744.
21. Masand, P. S., & Tesar, G. E. (1996). Use of stimulants in the medically ill. Psychiatric Clinics of North America, 19, 515-547.
22. McNeil, K., Newman, I., & Kelly, F. J. (1996). Statistical control of possible confounding variables, Testing research hypotheses with the general linear model (pp. 168-172). Carbondale: Southern Illinois University Press.
23. Nadder, T. S., Silberg, J. L., Eaves, L. J., Maes, H. H., & Meyer, J. M. (1998). Genetic effects on ADHD symptomatology in 7-to 13-year old twins: Results from a telephone survey. Behavior Genetics, 28, 83-99.
24. Papa, M., Berger, D. F., Sagvolden, T., Sergeant, J. A., & Sadile, A. G. (1998). A quantitative cytochrome oxidase mapping study, cross-regional and neurobehavioural correlations in the anterior forebrain of an animal model of attention-deficit hyperactivity disorder. Behavioural Brain Research, 94, 197-211.
25. Rowe, D. C., Stever, C., Giedinghagen, L. N., Gard, J. M. C., Cleveland, H. H., Terris, S. T., Mohr, J. H., Sherman, S., Abramowitz, A., & Waldman, I. D. (1998). Dopamine DRD4 receptor polymorphism and attention deficit hyperactivity disorder. Molecular Psychiatry, 3, 419-426.
26. 3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of attention-deficit hyperactivity disorder. Behavioural Brain Research, 94, 163-171.
27. Sagvolden, T., Aase, H., Zeiner, P., & Berger, D. (1998). Altered reinforcement mechanisms in attention-deficit/hyperactivity disorder. Behavioural Brain Research, 94, 61-71.
28. Sagvolden, T., Metzger, M. A., Schiobeck, H. K., Rugland, A. L., Spinangr, I., & Sagvolden, G. (1992). The spontaneously hypertensive rat (SHR) as an animal model of childhood hyperactivity (ADHD): Changed reactivity to reinforcers and to psychomotor stimulants. Behavioral and Neural Biology, 58, 103-112.
29. Sherman, D. K., Iacono, W. G., & McGue, M. K. (1997). Attention-deficit hyperactivity disorder dimensions: A twin study of inattention and impulsivity-hyperactivity. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 745-753.
30. Silberg, J., Rutter, M., Meyer, J., Maes, H., Hewitt, J., Simonoff, E., Pickles, A., Loeber, R., & Eaves, L. (1996). Genetic and environmental influences on the covariation between hyperactivity and conduct disturbance in juvenile twins. Journal of Child Psychology and Psychiatry, 37, 803-816.
31. Solanto, M. V. (1998). Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: A review and integration. Behavioural Brain Research, 94, 127-152.
32. Speer, D. (1992). Clinically significant change: Jacobson and Truax (1991) revisited. Journal of Consulting and Clinical Psychology, 60, 402-408.
33. Spencer, T., Biederman, J., Wilens, T., Harding, M., O'Donnell, D., & Griffin, S. (1996). Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 409-432.
34. Sprague, R. L., & Sleator, E. K. (1977). Methylphenidate in hyperkinetic children: Differences in dose effects on learning and social behavior. Science, 198, 1274-1276.
35. Wilens, T. E., & Biederman, J. (1992). The stimulants. Psychiatric Clinics of North America, 15, 191-222.
36. Zametkin, A. J., & Rapoport, J. L. (1987). Neurobiology of attention deficit disorder with hyperactivity: Where have we come in 50 years? Journal of the American Academy of Child and Adolescent Psychiatry, 26, 676-686.